Mirum Pharmaceuticals Inc... (MIRM)

MIRM trades at $72.76, 61.7% above the near-term max pain of $45 expiring Oct 17, 2025 (18 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($40-$70), reflecting growing call interest at higher strikes. Key magnetic zone at 50 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for MIRM shows an upward trend from 40 to 70, suggesting bullish positioning in longer-dated options. The 59% spread signals divergent expectations across timeframes. Most levels below 72.76 may cap rallies. Strong magnetic level at 50 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.